✦ LIBER ✦

A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: A Southwest Oncology Group Study

✍ Scribed by Robert P. Whitehead; Jacqueline K. Benedetti; James L. Abbruzzese; Bach Ardalan; J. Wendall Goodwin; Stanley P. Balcerzak; Wolfram E. Samlowski; Heinz-Josef Lenz; John S. Macdonald

Book ID: 111579915
Publisher: Springer US
Year: 2004
Tongue: English
Weight: 71 KB
Volume: 22
Category: Article
ISSN: 0167-6997
DOI: 10.1023/b:drug.0000026261.76197.54

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II pilot study of high-dose 24-h

A phase II pilot study of high-dose 24-hour continuous infusion of 5-FU and leucovorin and low-dose PALA for patients with colorectal cancer: A Southwest Oncology Group study

✍ Robert P. Whitehead; Jacqueline K. Benedetti; James L. Abbruzzese; Bach Ardalan; 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 70 KB

Evaluation of low dose continuous infusi

Evaluation of low dose continuous infusion 5-fluorouracil in patients with advanced and recurrent renal cell carcinoma. A Southwest Oncology Group study

✍ Julie A. Kish; Michael Wolf; E. David Crawford; Joseph T. Leimert; Anton Buesche 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 2 views

Background. The response rate of metastatic renal cell cancer to cytotoxic therapy over the last 10 years has been 5.6%. Low dose continuous 5-fluorouracil(5-FU) has demonstrated efficacy in other cytotoxic refractory tumors, such as pancreas, colorectal, and recurrent breast. The Southwest Oncology

A Phase II Trial of Etoposide, Leucovori

A Phase II Trial of Etoposide, Leucovorin, 5-FU, and Interferon Alpha 2b (ELFI) + G-CSF for Patients with Pancreatic Adenocarcinoma: a Southwest Oncology Group Study (SWOG 9413)

✍ John S. Macdonald; Joth L. Jacobson; Manuel Modiano; Dennis F. Moore; David R. G 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 48 KB

A phase I, II study of high-dose 5-fluor

A phase I, II study of high-dose 5-fluorouracil and high-dose leucovorin with low-dose phosphonacetyl-L-aspartic acid in patients with advanced malignancies

✍ Bach Ardalan; Kasi S. Sridhar; Pasquale Benedetto; Stephen Richman; Stuart Waldm 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 454 KB 👁 3 views

Continuous infusion of high-dose 5-fluor

Continuous infusion of high-dose 5-fluorouracil in combination with leucovorin and recombinant interferon-alpha-2b in patients with advanced colorectal cancer. A multicenter phase II study

✍ Cornelis J. A. Punt; Jos Th. M. Burghouts; Jelle J. Croles; Peter A. van Liessum 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB 👁 2 views

A phase II multi-institutional trial of

A phase II multi-institutional trial of low-dose N-(phosphonacetyl)-L-aspartate and high-dose 5-fluorouracil as a short-term infusion in the treatment of adenocarcinoma of the pancreas. A southwest oncology group study

✍ Louise M. Morrell; Ardalan Bach; Stephen P. Richman; Phyllis Goodman; Thomas R. 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 303 KB 👁 2 views